Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment

ClinicalTrials.gov ID: NCT03446001

Public ClinicalTrials.gov record NCT03446001. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 2, 2026, 5:27 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Placebo-Controlled, Three-Arm, 12-Month, Safety and Efficacy Study of TRx0237 Monotherapy in Subjects With Alzheimer's Disease Followed by a 12-Month Open-Label Treatment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the safety and efficacy of TRx0237 16 mg/day and 8 mg/day in the treatment of subjects with Alzheimer's Disease compared to placebo. In addition, an open-label, delayed-start phase is included to demonstrate a disease-modifying effect of TRx0237.

Study identification

NCT ID
NCT03446001
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
TauRx Therapeutics Ltd
Industry
Enrollment
598 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Up to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 1, 2017 (Actual)
Primary completion
Mar 31, 2022 (Actual)
Completion
Apr 4, 2023 (Actual)
Last update posted
Sep 4, 2025

2017 – 2023

United States locations

U.S. sites
60
U.S. states
15
U.S. cities
47
Facility City State ZIP Site status
Xenoscience Phoenix Arizona 85004 —
Arizona Research Center Phoenix Arizona 85053 —
Imaging Endpoints Research Scottsdale Arizona 85258 —
Atria Clinical Research Little Rock Arkansas 72209 —
ATP Clinical Research, Inc. Costa Mesa California 92626 —
HB Clinical Trials Inc. Fountain Valley California 92708 —
Fullerton Neurology and Headache Center Fullerton California 92835 —
Senior Clinical Trials, Inc. Laguna Hills California 92653 —
Hoag Memorial Hospital Presbyterian Newport Beach California 92663 —
Excell Research, Inc. Oceanside California 92056 —
Sharp Mesa Vista Hospital San Diego California 92123 —
Syrentis Clinical Research Santa Ana California 92705 —
California Neuroscience Medical Group Sherman Oaks California 91403 —
Visionary Investigators Network Aventura Florida 33180 —
Finlay Medical Research Greenacres City Florida 33467 —
MD Clinical Hallandale Florida 33009 —
Indago Research & Health Center, Inc. Hialeah Florida 33012 —
Merrit Island Medical Research Merritt Island Florida 32952 —
Health Care Family Rehab and Research Miami Florida 33015 —
Optimus Clinical Research Miami Florida 33125 —
Biomed Research Institute, Inc Miami Florida 33126 —
Finlay Medical Research Miami Florida 33126 —
CCM Clinical Research Group Miami Florida 33133 —
Advance Medical Research Center Miami Florida 33135 —
Vitae Research Center, LLC Miami Florida 33135 —
L&C Professional Medical Research Institute Miami Florida 33144 —
Allied Biomedical Research Institute Miami Florida 33155 —
Future Care Solution, LLC Miami Florida 33165 —
Florida International Research Center Miami Florida 33173 —
Miami Dade Medical Research Institute, LLC Miami Florida 33176 —
Visionary Investigators Network Miami Florida 33176 —
Sensible Healthcare Ocoee Florida 34761 —
Bioclinica Research Orlando Florida 32806 —
IMIC Inc Palmetto Bay Florida 33157 —
Emerald Coast Center for Neurological Disorders Pensacola Florida 32504 —
Progressive Medical Research Port Orange Florida 32127 —
The Roskamp Institute, Inc. Sarasota Florida 34243 —
Stedman Clinical Trials Tampa Florida 33613 —
Alzheimer's Research and Treatment Center Wellington Florida 33414 —
NeuroStudies.net, LLC Decatur Georgia 30033 —
Georgia Neurology and Sleep Medicine Associates Suwanee Georgia 30024 —
Josephson Wallack Munshower Neurology P.C. Indianapolis Indiana 46256 —
Advanced Memory Research of NJ PC Toms River New Jersey 08755 —
Albany Medical College Albany New York 12208 —
UBMD Neurology Buffalo New York 14203 —
Richmond Behavioral Associates Staten Island New York 10312 —
Alzheimer's Memory Center Charlotte North Carolina 28270 —
Neuroscience Research Center, LLC Canton Ohio 44718 —
Valley Medical Research Centerville Ohio 45459 —
The Lindner Research Center Cincinnati Ohio 45219 —
Neurology Diagnostics Inc. Dayton Ohio 45459 —
Neuro-Behavioral Clinical Research, Inc. North Canton Ohio 44321 —
IPS Research Company Oklahoma City Oklahoma 73106 —
Tulsa Clinical Research LLC Tulsa Oklahoma 74136 —
Neural Net Research Portland Oregon 97225 —
CBRI - Roper Hospital Charleston South Carolina 29414 —
Coastal Neurology Port Royal South Carolina 29935 —
Re:Cognition Health Fairfax Virginia 22031 —
Kingfisher Cooperative, LLC Spokane Washington 99202 —
Universal Research Group, LLC Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03446001, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 4, 2025 · Synced Nov 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03446001 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →